The concentration of circulating chemerin was increased in patients with AAA, and the analysis of abdominal aortic samples from AAA patients revealed increased mRNA levels of both chemerin and CMKRL1 relative to healthy controls, suggesting the involvement of chemerin/CMRKL1 axis in AAA pathogenesis and progression [158]. This evidence concerns the gene RARRES2 and triple-A syndrome.